18.600
−2,62%
2026-09-16
Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -134.4% | +3758.6% | 2 / 3 | +11.3% | -1.62 pp | -4.41 pp | — | 0.00 | 11.85 | 29,0 | +11,3% | −0,3 | −135,1% | 11.85 | 13.48 | −12,1% |
| Pts | 0 | 12 | 8 | 4 | 4 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 18.600 (close price on 2026-09-16)EPS (TTM): 1.570
Financial charts
1.Revenue & growth
VND bn29,0Q2/26
1.Revenue & growth
VND bn29,0Q2/26
2.Profit & growth
VND bn-0,27Q2/26
3.Profit mix (Penman)
VND bn6,01Q2/26
4.Margins & cost structure
%9.6%Q2/26
5.Returns & cash cycle
% · days5.9%Q2/26
6.Earnings quality & cash
VND bn17,0Q2/26
7.Asset structure
VND bn70,6Q2/26
8.Funding & debt health
VND bn · times70,6Q2/26
9.Revenue backlog
VND bn0,62Q2/26
10.Valuation
times · %11,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-88Q2/26
Adjusted EPS growth, latest quarter
-131%
Average adjusted EPS growth, 3 quarters
45,9× higher
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26